Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.960
-0.070 (-6.81%)
Nov 21, 2024, 11:19 AM EST - Market open
Lyell Immunopharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Lyell Immunopharma stock have an average target of 1.00, which predicts an increase of 4.18% from the current stock price of 0.96.
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for LYEL stock from 2 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +4.18% | Nov 12, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $6 → $1 | Strong Buy → Sell | Downgrades | $6 → $1 | +4.18% | Oct 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +4.18% | Oct 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +4.18% | Aug 19, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $9 → $6 | Strong Buy | Maintains | $9 → $6 | +525.07% | Jun 27, 2024 |
Financial Forecast
Revenue This Year
8.16K
from 130.00K
Decreased by -93.72%
Revenue Next Year
n/a
from 8.16K
EPS This Year
-0.85
from -0.93
EPS Next Year
-0.86
from -0.85
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 16,800 | n/a | n/a |
| Avg | 8,160 | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -87.1% | - | - |
| Avg | -93.7% | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.82 | -0.83 | -0.82 |
| Avg | -0.85 | -0.86 | -0.82 |
| Low | -0.91 | -0.90 | -0.80 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.